TrialJournal of gastroenterology2019

Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.

Toshihisa Takeuchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.